RESUMO
The synthesis and antiproliferative activity of Mes- and iPr-substituted gold(I) bis(1,2,3-triazol-5-ylidene) complexes in various cancer cell lines are reported, showing nanomolar IC50 values of 50 nM (lymphoma cells) and 500 nM (leukemia cells), respectively (Mes < iPr). The compounds exclusively induce apoptosis (50 nM to 5 µM) instead of necrosis in common malignant blood cells (leukemia cells) and do not affect non-malignant leucocytes. Remarkably, the complexes not only overcome resistances against the well-established cytostatic etoposide, cytarabine, daunorubicin, and cisplatin but also promote a synergistic effect of up to 182% when used with daunorubicin. The present results demonstrate that gold(I) bis(1,2,3-triazol-5-ylidene) complexes are highly promising and easily modifiable anticancer metallodrugs.
Assuntos
Antineoplásicos/farmacologia , Complexos de Coordenação/farmacologia , Ouro/química , Triazóis/química , Antineoplásicos/química , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Complexos de Coordenação/química , Daunorrubicina/farmacologia , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Sinergismo Farmacológico , HumanosRESUMO
The synthesis of trans axially substituted mono- (1 a) and bis(tert-butylisocyanide) (1 b) derivatives of the highly active homogeneous bio-inspired iron(II) olefin epoxidation (pre-)catalyst 1 bearing an equatorial macrocyclic tetra N-heterocyclic carbene and two trans axial labile acetonitrile ligands is reported. NMR spectroscopy and SC-XRD indicate a considerable π-backdonation from the iron(II) centres to the isocyanide ligand(s). The impact of isocyanide substitution on the electronic features of the complexes is studied by cyclic voltammetry revealing a significant increase in half-cell potential assignable to the reversible Fe(II)/Fe(III) redox couple with an increasing number of isocyanides as a result of their π-accepting properties: E1/2 =0.15â V (1), E1/2 =0.35â V (1 a), E1/2 =0.44â V (1 b).
